-
901por Rie Sano, Yoichiro Takahashi, Haruki Fukuda, Megumi Harada, Akira Hayakawa, Takafumi Okawa, Rieko Kubo, Haruo Takeshita, Junichi Tsukada, Yoshihiko Kominato“... with biallelic deletions of the site created using the CRISPR/Cas9 system, relative to those in the wild-type...”
Publicado 2021
Enlace del recurso
article -
902por Claudia Bilodeau, Sharareh Shojaie, Olivia Goltsis, Jinxia Wang, Daochun Luo, Cameron Ackerley, Ian M Rogers, Brian Cox, Martin Post“... after injury. Removal of TP63 by CRISPR/Cas9 in the ES cells halted basal and airway cell...”
Publicado 2021
Enlace del recurso
article -
903por Charlotte Beck, Tetiana Gren, Francisco Javier Ortiz-López, Tue Sparholt Jørgensen, Daniel Carretero-Molina, Jesús Martín Serrano, José R. Tormo, Daniel Oves-Costales, Eftychia E. Kontou, Omkar S. Mohite, Erik Mingyar, Evi Stegmann, Olga Genilloud, Tilmann Weber“.... These methods include genome mining, proteomics and transcriptomics analyses, in combination with CRISPR induced...”
Publicado 2021
Enlace del recurso
article -
904por Samuel D. Zwernik, Beau H. Adams, Daniel A. Raymond, Catherine M. Warner, Amin B. Kassam, Richard A. Rovin, Parvez Akhtar“... of AXL receptor strongly attenuated virus entry in GBM cell lines. Additionally, CRISPR knockout...”
Publicado 2021
Enlace del recurso
article -
905por Sebastian Maximilian Altstetter, Oliver Quitt, Francesca Pinci, Veit Hornung, Aaron Michael Lucko, Karin Wisskirchen, Stephanie Jung, Ulrike Protzer“... (HBV), are poorly understood. Using CRISPR technology, we characterized the recognition of HDV mono...”
Publicado 2021
Enlace del recurso
article -
906por Alexandre Bokhobza, Nathalie Ziental-Gelus, Laurent Allart, Oksana Iamshanova, Fabien Vanden Abeele“... are dysregulated and lead to abnormal migration and/or cell proliferation. In the present study, we used the CRISPR...”
Publicado 2021
Enlace del recurso
article -
907por Carlos A Capoano, Luis Adrián Ortiz-Laquintana, Rosana Rodríguez-Casuriaga, Geraldine Schlapp, María Noel Meikle, Ana Paula Mulet, Martina Crispo, Ricardo Benavente, Adriana Geisinger“... model using CRISPR/Cas9 technology. The phenotypic analysis showed no overt phenotype in Spats1-/- mice...”
Publicado 2021
Enlace del recurso
article -
908por Zhi-Luo Deng, Szymon P. Szafrański, Michael Jarek, Sabin Bhuju, Irene Wagner-Döbler“..., flagellar assembly, type III secretion system, type III CRISPR-Cas system, and two component system proteins...”
Publicado 2017
Enlace del recurso
article -
909por Kylie H. Van der Hoek, Nicholas S. Eyre, Byron Shue, Onruedee Khantisitthiporn, Kittirat Glab-Ampi, Jillian M. Carr, Matthew J. Gartner, Lachlan A. Jolly, Paul Q. Thomas, Fatwa Adikusuma, Tanja Jankovic-Karasoulos, Claire T. Roberts, Karla J. Helbig, Michael R. Beard“... impairment of ZIKV replication, while MEFs derived from CRISPR/Cas9 derived viperin−/− mice replicated ZIKV...”
Publicado 2017
Enlace del recurso
article -
910por Anna Moskovskich, Ulrich Goldmann, Felix Kartnig, Sabrina Lindinger, Justyna Konecka, Giuseppe Fiume, Enrico Girardi, Giulio Superti-Furga“... CRISPR knockout library. Genetic screens with the cytolytic vesicular stomatitis virus (VSV) showed...”
Publicado 2019
Enlace del recurso
article -
911por Jonathan Yen, Michael Fiorino, Yi Liu, Steve Paula, Scott Clarkson, Lisa Quinn, William R. Tschantz, Heath Klock, Ning Guo, Carsten Russ, Vionnie W. C. Yu, Craig Mickanin, Susan C. Stevenson, Cameron Lee, Yi Yang“...Abstract CRISPR/Cas9 mediated gene editing of patient-derived hematopoietic stem and progenitor...”
Publicado 2018
Enlace del recurso
article -
912por Adrián Sánchez-Fdez, María Florencia Re-Louhau, Pablo Rodríguez-Núñez, Dolores Ludeña, Sofía Matilla-Almazán, Atanasio Pandiella, Azucena Esparís-Ogando“... disruption of ERK5 by CRISPR/Cas9 caused a relevant inhibition of tumor growth in vitro and in vivo; such ERK...”
Publicado 2021
Enlace del recurso
article -
913por Tuba Korkmaz, Fatih Aygenli, Handan Emisoglu, Gozde Ozcelik, Asena Canturk, Secil Yilmaz, Nuri Ozturk“...1 gene with CRISPR technology. We preferred epithelial cells over fibroblasts as the most of cancers...”
Publicado 2018
Enlace del recurso
article -
914“... (GM) mouse model with the MLC enhancer incorporated by CRISPR/Cas9 technology. The GM mice exhibited...”
Enlace del recurso
article -
915por Glenn A. MacLean, Jennifer McEldoon, Jialiang Huang, Jeremy Allred, Matthew C. Canver, Stuart. H. Orkin“... of the EDNRB pathway in B cell differentiation was obtained through CRISPR/Cas9 gene targeting in disomic...”
Publicado 2018
Enlace del recurso
article -
916“... range of cell types, and also enable robust delivery of CRISPR-Cas9 effectors. Taken together, we...”
Enlace del recurso
article -
917por Aida M. Lopez-Guerrero, Patricia Tomas-Martin, Carlos Pascual-Caro, Thomas Macartney, Alejandro Rojas-Fernandez, Graeme Ball, Dario R. Alessi, Eulalia Pozo-Guisado, Francisco Javier Martin-Romero“... by CRISPR/Cas9 genome editing in U2OS cells. In both cases, KO cells presented a notable reduction of store...”
Publicado 2017
Enlace del recurso
article -
918por N. Facchinello, T. Skobo, G. Meneghetti, E. Colletti, A. Dinarello, N. Tiso, R. Costa, G. Gioacchini, O. Carnevali, F. Argenton, L. Colombo, L. Dalla Valle“... through the transcriptional activity of their cognate receptor (Gr). Using CRISPR/Cas9 technology, we...”
Publicado 2017
Enlace del recurso
article -
919por Ella Thomson, Ruby Dawson, Chee Ho H’ng, Fatwa Adikusuma, Sandra Piltz, Paul Q. Thomas“... in cultured cells and in vivo. We generated CRISPR deletions of the enhancer region in mice and assessed...”
Publicado 2021
Enlace del recurso
article -
920